Austin Heart, a provider of cardiac and vascular services, has started enrolling peripheral arterial disease (PAD) patients for Avinger's Connect II trial. The multi-center, non-randomized and prospective trial is designed to evaluate ...
Tags: Austin Heart, PAD patients, Connect II trial, peripheral arterial disease
Avinger has reported that it will present the CONNECT II clinical trial results at the Vascular Interventional Advances (VIVA) conference being held in Las Vegas, Nevada, US, between 9-12 October 2012. The prospective, multi-center, ...
Avinger has completed enrolling peripheral artery disease (PAD) patients in its CONNECT II clinical trial. The prospective, multi-center, non-randomized trial that evaluated 100 PAD patients with femoropopliteal CTO lesions was ...
Tags: clinical trial, peripheral artery disease, clinical technology, Avinger